QUOTED. 5 July 2019. Jayanth Katta.
Executive Summary
No matter the outcome of Brexit, notified body BSI UK has confirmed it will maintain a medtech business in the UK. See what BSI UK's Jayanth Katta said about it here.
“Under a no-deal scenario, BSI intends to continue operating as a UK notified body and maintain the CE certificates issued by BSI UK Notified Body.” – Jayanth Katta, regulatory lead, BSI UK
Click here for a free trial of Medtech Insight